lactic acid has been researched along with Atrial Septal Defect in 8 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the fiber-degradation and endothelialization of a modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluder for a long time in vivo." | 8.31 | Assessment of degradability and endothelialization of modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluders over time in vivo. ( Chen, J; Chen, X; Fu, M; Li, Y; Liu, Y; Xie, Y; Zhang, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 1 |
| Xie, Y | 1 |
| Li, Y | 1 |
| Chen, X | 1 |
| Fu, M | 1 |
| Liu, Y | 1 |
| Zhang, Z | 1 |
| Liu, SJ | 1 |
| Peng, KM | 1 |
| Hsiao, CY | 1 |
| Liu, KS | 1 |
| Chung, HT | 1 |
| Chen, JK | 1 |
| Dong, MF | 1 |
| Ma, ZS | 1 |
| Wang, JT | 1 |
| Chai, SD | 1 |
| Tang, PZ | 1 |
| Wang, LX | 1 |
| HOLMGREN, A | 1 |
| STROM, G | 1 |
| Photiadis, J | 1 |
| Urban, AE | 1 |
| Sinzobahamvya, N | 1 |
| Fink, C | 1 |
| Schindler, E | 1 |
| Schneider, M | 1 |
| Marie Brecher, A | 1 |
| Asfour, B | 1 |
| Laussen, PC | 1 |
| Murphy, JA | 1 |
| Zurakowski, D | 1 |
| Sullivan, LJ | 1 |
| McGowan, FX | 1 |
| Demaso, DR | 1 |
| Wollert, HG | 1 |
| Müller, W | 1 |
| Fischer, D | 1 |
| Wollert, U | 1 |
| Schubert, F | 1 |
| Krause, EG | 1 |
| Panzner, R | 1 |
| Nakada, I | 1 |
8 other studies available for lactic acid and Atrial Septal Defect
| Article | Year |
|---|---|
Assessment of degradability and endothelialization of modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluders over time in vivo.
Topics: Animals; Atrial Septum; Cardiac Catheterization; Echocardiography; Follow-Up Studies; Heart Septal D | 2023 |
Novel biodegradable polycaprolactone occlusion device combining nanofibrous PLGA/collagen membrane for closure of atrial septal defect (ASD).
Topics: Cell Adhesion; Cell Culture Techniques; Cell Proliferation; Collagen; Heart Septal Defects, Atrial; | 2011 |
Impact of peripherally established cardiopulmonary bypass on regional and systemic blood lactate levels.
Topics: Acidosis, Lactic; Adolescent; Adult; Carbon Dioxide; Cardiopulmonary Bypass; Child; Child, Preschool | 2012 |
Blood lactate concentration in relation to absolute and relative work load in normal men, and in mitral stenosis, atrial septal defect and vasoregulatory asthenia.
Topics: Asthenia; Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Atrial; Heart Septu | 1959 |
Restrictive left atrial outflow adversely affects outcome after the modified Norwood procedure.
Topics: Aortic Valve; Chi-Square Distribution; Heart Septal Defects, Atrial; Hemodynamics; Humans; Hypoplast | 2005 |
Bispectral index monitoring in children undergoing mild hypothermic cardiopulmonary bypass.
Topics: Adolescent; Blood Pressure; Cardiopulmonary Bypass; Child; Child, Preschool; Cohort Studies; Electro | 2001 |
[Heart surgery interventions in risk patients. New possibilities for improving therapeutic results].
Topics: Adult; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Energy Metaboli | 1990 |
[The effect of the ultrafiltration during and after cardiopulmonary bypass].
Topics: Adult; Body Fluids; Cardiopulmonary Bypass; Female; Heart Septal Defects, Atrial; Humans; Lactates; | 1988 |